Endocarditis causes: Difference between revisions
Jump to navigation
Jump to search
(/* Epidemiological Clues in Etiological Diagnosis of Culture-Negative Endocarditis{{Cite journal | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5...) |
|||
(4 intermediate revisions by 4 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The majority of cases of infective endocarditis are due to bacteria. Common causes of infective endocarditis include ''[[Streptococcus viridans]]'', ''[[Staphylococcus aureus|Staphylococci]]'', and ''[[Enterococcus]]''. | The majority of cases of infective endocarditis are due to bacteria. Common causes of infective endocarditis include ''[[Streptococcus viridans]]'', ''[[Staphylococcus aureus|Staphylococci]]'', and ''[[Enterococcus]]''. | ||
==Causes== | ==Causes== | ||
===Common Causes=== | ===Common Causes=== | ||
*[[Staphylococcus aureus]]<ref name="Murdoch">{{cite journal|last=Murdoch|first=DR|title=Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study|journal=Archives of Internal Medicine|date=9 March 2009|volume=169|issue=5|pages=463–73|pmid=19273776|doi=10.1001/archinternmed.2008.603|pmc=3625651|display-authors=etal}}</ref> | |||
*[[Streptococcus viridans]] | |||
*[[Coagulase]] negative [[Staphylococci]] | |||
*[[Candida albicans]] | *[[Candida albicans]] | ||
*[[clostridium|Clostridium septicum]] | *[[clostridium|Clostridium septicum]] | ||
*[[Enterococcus]] | *[[Enterococcus]] | ||
*[[HACEK organisms]] | *[[HACEK organisms]] | ||
*[[Pseudomonas | *[[Pseudomonas]] | ||
*[[Streptococcus bovis]] | *[[Streptococcus bovis]] | ||
*[[Streptococcus | *[[Streptococcus pneumoniae]] | ||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
Line 133: | Line 130: | ||
|- | |- | ||
|} | |} | ||
==Epidemiological Clues in Etiological Diagnosis of Culture-Negative Endocarditis<ref>{{Cite journal | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref>== | ==Epidemiological Clues in Etiological Diagnosis of Culture-Negative Endocarditis<ref>{{Cite journal | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref>== | ||
Line 350: | Line 137: | ||
! Epidemiological features || Common Microorganism(s) | ! Epidemiological features || Common Microorganism(s) | ||
|- | |- | ||
!<center>'''Injection drug use'''</center> | |||
| | |||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
*Oxacillin-resistant strains | *Oxacillin-resistant strains | ||
Line 359: | Line 147: | ||
:*[[Pseudomonas aeruginosa]] | :*[[Pseudomonas aeruginosa]] | ||
|- | |- | ||
!<center>'''Indwelling cardiovascular medical devices'''</center> | |||
| | |||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
*Coagulase-negative staphylococci | *Coagulase-negative staphylococci | ||
Line 366: | Line 155: | ||
*[[Corynebacterium]] sp | *[[Corynebacterium]] sp | ||
|- | |- | ||
!<center>'''Genitourinary disorders'''</center> | |||
<center>'''Genitourinary infection'''</center> | <center>'''Genitourinary infection'''</center> | ||
Line 384: | Line 173: | ||
*[[Neisseria gonorrhoeae]] | *[[Neisseria gonorrhoeae]] | ||
|- | |- | ||
!<center>'''Chronic skin disorders''' </center> | |||
| | |||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
*[[Streptococcus|β-Hemolytic streptococci]] | *[[Streptococcus|β-Hemolytic streptococci]] | ||
|- | |- | ||
!<center>'''Poor dental health, dental procedures''' </center> | |||
| | |||
*Viridans group streptococci | *Viridans group streptococci | ||
*“Nutritionally variant streptococci” | *“Nutritionally variant streptococci” | ||
Line 396: | Line 187: | ||
*[[HACEK organism]]s | *[[HACEK organism]]s | ||
|- | |- | ||
!<center>'''Alcoholism, cirrhosis''' </center> | |||
| | |||
*[[Streptococcus pneumoniae|S pneumoniae]] | *[[Streptococcus pneumoniae|S pneumoniae]] | ||
*[[Streptococcus|β-Hemolytic streptococci]] | *[[Streptococcus|β-Hemolytic streptococci]] | ||
Line 405: | Line 197: | ||
*[[Aeromonas hydrophila|Aeromonas sp]] | *[[Aeromonas hydrophila|Aeromonas sp]] | ||
|- | |- | ||
!<center>'''Burn patients''' </center> | |||
| | |||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
*Aerobic Gram-negative bacilli, including | *Aerobic Gram-negative bacilli, including | ||
Line 411: | Line 204: | ||
*[[Fungi]] | *[[Fungi]] | ||
|- | |- | ||
!<center>'''Diabetes mellitus''' </center> | |||
| | |||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
*[[Streptococcus|β-Hemolytic streptococci]] | *[[Streptococcus|β-Hemolytic streptococci]] | ||
*[[Streptococcus pneumoniae|S pneumoniae]] | *[[Streptococcus pneumoniae|S pneumoniae]] | ||
|- | |- | ||
!<center>'''Early ( < 1 y) prosthetic valve placement''' </center> | |||
| | |||
*Coagulase-negative staphylococci | *Coagulase-negative staphylococci | ||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
Line 424: | Line 219: | ||
*[[Legionella|Legionella sp]] | *[[Legionella|Legionella sp]] | ||
|- | |- | ||
!<center>'''Late ( > 1 y) prosthetic valve placement''' </center> | |||
| | |||
*Coagulase-negative staphylococci | *Coagulase-negative staphylococci | ||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
Line 432: | Line 228: | ||
*[[Corynebacterium]] sp | *[[Corynebacterium]] sp | ||
|- | |- | ||
!<center>'''Dog–cat exposure''' </center> | |||
| | |||
*[[Bartonellosis|Bartonella sp]] | *[[Bartonellosis|Bartonella sp]] | ||
*[[Pasteurella multocida|Pasteurella sp]] | *[[Pasteurella multocida|Pasteurella sp]] | ||
*[[Capnocytophaga|Capnocytophaga sp]] | *[[Capnocytophaga|Capnocytophaga sp]] | ||
|- | |- | ||
!<center>'''Contact with contaminated milk'''</center> | |||
<center>'''Contact with infected farm animals'''</center> | <center>'''Contact with infected farm animals'''</center> | ||
|| | || | ||
Line 444: | Line 241: | ||
*[[Erysipelothrix rhusiopathiae|Erysipelothrix sp]] | *[[Erysipelothrix rhusiopathiae|Erysipelothrix sp]] | ||
|- | |- | ||
!<center>'''Homeless, body lice'''</center> | |||
| | |||
*[[Bartonellosis|Bartonella sp]] | *[[Bartonellosis|Bartonella sp]] | ||
|- | |- | ||
!<center>'''AIDS'''</center> | |||
| | |||
*[[Salmonella|Salmonella sp]] | *[[Salmonella|Salmonella sp]] | ||
*[[Streptococcus pneumoniae|S pneumoniae]] | *[[Streptococcus pneumoniae|S pneumoniae]] | ||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
|- | |- | ||
!<center>'''Pneumonia, meningitis'''</center> | |||
| | |||
*[[Streptococcus pneumoniae|S pneumoniae]] | *[[Streptococcus pneumoniae|S pneumoniae]] | ||
|- | |- | ||
!<center>'''Solid organ transplant'''</center> | |||
| | |||
*[[Staphylococcus aureus|S. aureus]] | *[[Staphylococcus aureus|S. aureus]] | ||
*[[Aspergillus|Aspergillus fumigatus]] | *[[Aspergillus|Aspergillus fumigatus]] | ||
Line 461: | Line 262: | ||
*[[Candida albicans|Candida sp]] | *[[Candida albicans|Candida sp]] | ||
|- | |- | ||
!<center>'''Gastrointestinal lesions'''</center> | |||
| | |||
*[[Streptococcus bovis|S bovis]] | *[[Streptococcus bovis|S bovis]] | ||
*[[Enterococcus|Enterococcus sp]] | *[[Enterococcus|Enterococcus sp]] | ||
Line 473: | Line 275: | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] |
Latest revision as of 02:13, 6 March 2020
Endocarditis Microchapters |
Diagnosis |
---|
Treatment |
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease |
Case Studies |
Endocarditis causes On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2] Ogheneochuko Ajari, MB.BS, MS [3]
Overview
The majority of cases of infective endocarditis are due to bacteria. Common causes of infective endocarditis include Streptococcus viridans, Staphylococci, and Enterococcus.
Causes
Common Causes
- Staphylococcus aureus[1]
- Streptococcus viridans
- Coagulase negative Staphylococci
- Candida albicans
- Clostridium septicum
- Enterococcus
- HACEK organisms
- Pseudomonas
- Streptococcus bovis
- Streptococcus pneumoniae
Causes by Organ System
Epidemiological Clues in Etiological Diagnosis of Culture-Negative Endocarditis[2]
Epidemiological features | Common Microorganism(s) |
---|---|
| |
| |
| |
| |
| |
| |
| |
References
- ↑ Murdoch, DR; et al. (9 March 2009). "Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study". Archives of Internal Medicine. 169 (5): 463–73. doi:10.1001/archinternmed.2008.603. PMC 3625651. PMID 19273776.
- ↑ Baddour, LM.; Wilson, WR.; Bayer, AS.; Fowler, VG.; Bolger, AF.; Levison, ME.; Ferrieri, P.; Gerber, MA.; Tani, LY. (2005). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): e394–434. doi:10.1161/CIRCULATIONAHA.105.165564. PMID 15956145. Unknown parameter
|month=
ignored (help)